Answers are grounded in this paper and cite their sources.
Background: Growing evidence indicates that long non-coding RNAs (lncRNAs) play critical roles in sepsis. However, the potential function of lncRNA MIR3945HG in sepsis remains unclear. Objective: This study aimed to investigate the role and molecular mechanism of lncRNA MIR3945HG in the LPS-induced inflammatory response and in PBMCs from sepsis patients. Methods: Blood samples were obtained from 40 sepsis patients and 21 age-matched healthy controls. A lipopolysaccharide (LPS)-challenged THP-1 human monocytic cell line served as the in vitro model of LPS-induced innate immune activation. Quantitative real-time polymerase chain reaction (qRT-PCR) quantified the expression of lncRNA MIR3945HG, miR-150-5p, and p50. Cell viability and apoptosis were evaluated with CCK-8 assay, PCNA, and Bcl-xL staining. The interaction between lncRNA MIR3945HG and miR-150-5p was validated by a dual-luciferase reporter assay. The levels of inflammatory cytokines were measured using an enzyme-linked immunosorbent assay (ELISA). Results: lncRNA MIR3945HG was significantly upregulated in sepsis patients and LPS-stimulated THP-1 cells. Genetic knockout of lncRNA MIR3945HG enhanced THP-1 cell viability and simultaneously curtailed both cell apoptosis and the inflammation response. Conversely, miR-150-5p depletion reversed the cytoprotective and anti-inflammatory benefits elicited by lncRNA MIR3945HG knockout. Mechanistically, lncRNA MIR3945HG derepressed p50 expression through competing with miR-150-5p. Functional rescue experiments further verified that lncRNA MIR3945HG overexpression promoted inflammation in LPS-treated THP-1 cells. Conclusions: The lncRNA MIR3945HG is upregulated in PBMCs from sepsis patients and promotes LPS-induced inflammatory responses in THP-1 cells, partially through the miR-150-5p/p50 axis. These findings suggest that lncRNA MIR3945HG may represent a candidate diagnostic biomarker for sepsis; however, its clinical utility and therapeutic relevance require further validation.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: